Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Vericiguat in Real-life Patients with Heart Failure: The VERITA Study
Author(s): Mario Galván-Ruiz , Miguel Fernández de Sanmamed-Girón , María del Val Groba-Marco , et al Added: 2 months ago

Guidelines & Statements

Heart Failure
ESC 24: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi
Author(s): Mirvat Alasnag , Khaled Al-Shaibi Added: 1 year ago
ESC Congress 24 – Day 1 of the ESC Congress 2024 was filled with excitement as new clinical practice guidelines were unveiled, along with several highly anticipated Hot Line trials.Interventional experts Dr Mirvat Alasnag and Dr Khaled Al-Shaibi (King Fahd Armed Forces Hospital, SA) are concluding the first day by providing practical summaries of the key guidelines and offering critical insights… View more

Guidelines & Statements

Heart Failure
AHA 25: The FOOD-HF Trial
Author(s): Ambarish Pandey Added: 7 months ago
AHA Scientific Sessions 2025 – Dr Ambarish Pandey (University of Texas Southwestern Medical Center, US) presents findings from a randomized clinical trial comparing medically tailored meals versus produce supplements on heart failure readmissions and emergency department visits.The study was conducted across two centers in Dallas, Texas. Patients were randomized within two weeks following heart… View more

Prevention & Chronic Conditions

Heart Failure
ESC 25: Lifetime Benefits of Combination Therapy in HFpEF
Author(s): Muthiah Vaduganathan Added: 9 months ago
ESC Congress 2025 - Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, Boston, US) joins us to discuss findings from a trial investigating the lifetime benefits of combination therapy for patients with HFpEF by looking at individual level data from DELIVER, FINEARTS-HF and PARAGON-HF trials.Interview Questions:1. What is the reasoning behind the trial?2. What was the study design and patient… View more

Heart Failure
Novel Therapies in ATTR-CM
Author(s): Michelle Dimza , Georgia Vasilakis , Justin L Grodin Added: 8 months ago

Heart Failure
RELAXIN-LA Trial: Volenrelaxin Linked to Worsening Congestion in HFpEF
Added: 9 months ago Source:  Radcliffe Cardiology
Treatment with volenrelaxin, a long-acting human relaxin analogue, was associated with worsening congestion in patients with recently decompensated heart failure with preserved ejection fraction (HFpEF), leading to the early termination of the phase 2 RELAXIN-LA trial.¹ Despite this, the lowest dose of the drug did show an improvement in the study's primary endpoint.Relaxin is a peptide hormone… View more

Imaging & Diagnostics

Cardiovascular Kidney Metabolic
Free Light Chains in Heart Failure
Author(s): Akira Matsumori , Toshio Shimada , Hisayoshi Suma , et al Added: 3 weeks ago

Heart Failure
Giuseppe Mancia
Job title: Chairman of the Department of Clinical Medicine and Prevention
Giuseppe Mancia is an Italian physician and scientist internationally recognized for his lifelong contributions to cardiovascular medicine and hypertension research. He has spent the majority of his academic and clinical career in Milan and Monza, Italy, where he has played a central role in shaping modern hypertension research, education, and clinical practice across Europe and worldwide… View more
Advancing Patient Care in Hypertrophic Cardiomyopathy: Key Insights from the HFA 2024
Author(s): Ahmad Masri , Added: 2 years ago
Recorded during HFA 2024, Dr Caroline Coats, Glasgow University, UK, and Dr Ahmad Masri, Oregon Health and Science University, US, collaborate to explore the pivotal advancements in managing hypertrophic cardiomyopathy unveiled at the conference.This programme is thoughtfully divided into four chapters, facilitating a smooth journey through the latest HCM trial data, including a comprehensive… View more

Guidelines & Statements

Heart Failure
ESC 24: Hot Line & Late-breaking Science Video Collection
Author(s): Harriette Van Spall , Stefan James Added: 1 year ago
What's hot at the ESC Congress 2024?Stay ahead of the curve with our faculty-led coverage of the European Society of Cardiology Congress in London. From groundbreaking trials to expert insights, we've got you covered.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen.For a… View more

Intervention

MI/ACS